Sign in

CIK 0001875558

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Nuvectis Pharma, Inc.

Sign in to watch
Ticker
NVCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
862405608
Phone
+1 360-837-7232
Business address
1 BRIDGE PLAZA, SUITE 275, FORT LEE, NJ, 07024
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award Chief Science & Business Off acquired 60,000 shares (grant or award)
  3. 4 Grant or award Chief Dev. & Ops. Officer acquired 60,000 shares (grant or award)
  4. 4 Grant or award Chairman & CEO acquired 120,000 shares (grant or award)
  5. 4 Open-market buy Chairman & CEO bought 4,000 shares at $7.05 ($28,200)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market buy Chairman & CEO bought 7,000 shares at $7.63 ($53,410)
  8. 4 Open-market buy Chairman & CEO bought 8,000 shares at $5.88 ($47,040)
  9. 4 Open-market buy Chairman & CEO bought 8,500 shares at $6.34 ($53,890)
  10. 4 Open-market buy Chief Science & Business Off bought 4,600 shares at an average $3.44 ($15,834)
  11. 4 Open-market buy Chief Development Officer bought 2,946 shares at an average $3.41 ($10,034)
  12. 4 Open-market buy Chairman & CEO bought 232,500 shares at an average $4.96 ($1,153,145)
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership

Page 7 of 7 · 139 filings